People · Operator

RANDALL S. BARKO

Named in public records as an officer, director or promoter · active 2015–2019 · Manufacturing, Biotechnology

2
Companies
4
Filings
$67.8M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Parkway Holdings, LlcManufacturingSeries C$66.2M$113.2M2015
NED Biosystems, Inc.BiotechnologySeed$1.5M$66.9M2015
Operator network

RANDALL S. BARKO at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

EDWIN C. TAN · 3 companies · 1 sharedEDWIN C. TANBRIAN S. CARLTON · 1 companies · 1 sharedBRIAN S. CARLTONDANIEL S. EISMANN · 1 companies · 1 sharedDANIEL S. EISMANNJONATHAN DAVID HEARD · 1 companies · 1 sharedJONATHAN DAVID HE…MARK ALAN ALLSTEADT · 1 companies · 1 sharedMARK ALAN ALLSTEA…MARK C. LANGER · 1 companies · 1 sharedMARK C. LANGERR. ALAN RIDILLA · 1 companies · 1 sharedR. ALAN RIDILLARICHARD ALAN RIDILLA · 1 companies · 1 sharedRICHARD ALAN RIDI…Holly T. Sargent · 1 companies · 1 sharedHolly T. SargentMary G. Davis · 1 companies · 1 sharedMary G. DavisPeter S. D'Errico · 1 companies · 1 sharedPeter S. D'ErricoRebecca Lambert · 1 companies · 1 sharedRebecca LambertParkway Holdings, Llc · $66.2M raisedParkway Holdings, LlcNED Biosystems, Inc. · $1.5M raisedNED Biosystems, Inc.RANDALL S. BARKORB
RANDALL S. BARKO Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside RANDALL S. BARKO on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
EDWIN C. TAN13
R. ALAN RIDILLA11
MARK C. LANGER11
DANIEL S. EISMANN11
MARK ALAN ALLSTEADT11
Rebecca Lambert11
Peter S. D'Errico11
Mary G. Davis11
Holly T. Sargent11
RICHARD ALAN RIDILLA11
BRIAN S. CARLTON11
JONATHAN DAVID HEARD11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.